Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
extension tags : Europe save search
Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE(R) in the U.S. with Pentec Health
Published: 2023-07-19 (Crawled : 08:00) - biospace.com/
RLFTF | $1.4 11.45% 1.3K
|
n/a
|
| O: 3.0%
H: 2.91%
C: -2.91%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: -6.89%
H: 0.0%
C: 0.0%
health distribution extension therapeutics agreement
LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Published: 2023-06-06 (Crawled : 15:00) - biospace.com/
NVCR | $12.04 -0.08% -0.08% 1.4M
|
Health Technology
|
| O: -9.53%
H: 0.68%
C: -37.04%
lung cancer cell extension trial
Ideanomics receives NASDAQ extension to comply with Bid Price Rule and secures additional funding to increase EV and charging sales in the United States and Europe
Published: 2022-11-18 (Crawled : 11:00) - prnewswire.com
IDEX | $0.8903 9.11% 8.35% 210K
|
Technology Services
|
| O: 5.14%
H: 3.85%
C: 1.85%
sales europe nasdaq extension charging funding
Bicycle Therapeutics Announces Publication of Article in Bioconjugate Chemistry, Describing an Extension of its Proprietary Technology Platform Based on Bicyclic Peptides
Published: 2022-08-02 (Crawled : 23:00) - biospace.com/
BCYC | $24.51 12.33% 10.98% 500K
|
Health Technology
|
| O: 0.0%
H: 3.97%
C: 1.28%
extension technology therapeutics bicycle publication platform
Amryt to Present Data from OPTIMAL and MPOWERED Phase 3 Trials Open Label Extension of Mycapssa® (oral octreotide) at ENDO 2022
Published: 2022-06-08 (Crawled : 15:20) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
|
| O: 0.0%
H: 1.65%
C: -0.89%
mycapssa trials label phase 3
EMCORE Awarded Medallion 8100 L-EML™ Transmitter Contract Extension for Multi-Year Project in Europe
Published: 2022-04-13 (Crawled : 22:00) - globenewswire.com
EMKR 4 | $2.86 -1.72% -1.75% 310K
|
Electronic Technology
|
| O: 0.0%
H: 6.0%
C: 5.14%
europe multi-year contract
argenx Presents Interim Results from ADAPT+ Open-Label Extension Study Evaluating VYVGART® (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis at 2022 AAN Annual Meeting
Published: 2022-04-05 (Crawled : 07:00) - biospace.com/
ARGX | $358.65 -2.06% -2.11% 240K
|
Health Technology
|
| O: 1.03%
H: 1.06%
C: -1.2%
vyvgart results
Midatech Pharma PLC Announces Extension of Janssen collaboration re Q-Sphera
Published: 2022-01-17 (Crawled : 09:00) - biospace.com/
MTP | $0.4703 -70.79% -73.69% 0
|
Health Technology
| Email alert
Add to watchlist
collaboration pharma
Ascendis Pharma A/S Announces Extension of U.S. Food and Drug Administration Review Period for TransCon™ hGH
Published: 2021-06-11 (Crawled : 00:20) - biospace.com/
ASND | $140.98 -0.84% -0.84% 220K
|
Health Technology
|
| O: -0.67%
H: 2.33%
C: 2.27%
food drug pharma
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
AGBA | $1.02 155.0% 60.78% 120M
|
Finance
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 900K
|
OST | $0.499 21.38% 45.26% 1.9M
|
ZCMD | $2.44 78.1% 43.85% 330K
|
Commercial Services
XPON | $3.1 60.62% 37.74% 16M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.